Join CBMTG | Print Page | Contact Us | Sign In
2018 Annual Meeting Preliminary Program

Ottawa | June 6-9, 2018
Delta Hotel Ottawa, 101 Lyon St N, Ottawa

Pre-conference Day - Wednesday, June 6, 2018

Pre-registration and fee required for Leadership Training and BMT 101

8:00am – 4:00pm

 Leadership Training: Developing Strategic Focus in Your Life
Peter Craighead, MD, ChB

For a session description, please click here.

Space is limited to 30 participants, available on a first-come-first-served basis

 Leadership Competencies; Thinking Style Assessment

 Forming Your Own Strategic Plan

 How to Build Effective Teams and Know That They are Working  Well Together

 How to Lead Change (Including During Times of Transition and  Seizing Opportunities)

 1:00pm – 5:30pm

 BMT 101
Chair: Kylie Lepic, MD, FRCPC

 Opening Remarks
Kylie Lepic, MD, FRCPC

 Donor Screening and Selection
David Allan, MD, FRCPC

 Conditioning Regimens
Chris Bredeson, MD, MSc, FRCPC

 Infections Complications of Transplant
Arianne Buchan, MD, FRCPC

 Chronic Graft Versus Host Disease Treatment
Donna Wall, MD, CCPE 

 Introduction to Chimeric Antigen Receptor T-Cells
Natasha Kekre, BSc, MD, MPH, FRCPC

 Closing Remarks and Evaluation
Kylie Lepic, MD, FRCPC

7:00pm – 8:30pm 

 Nursing Networking Session

7:00pm – 8:30pm 

 Pharmacist Networking Session 

 Day 1 - Thursday, June 7, 2018

 7:00am – 8:45am

 Corporate Symposium with Breakfast 

 9:00am – 12:00pm

 Session 1
Chair: Lothar Huebsch, MD, FRCPC

 Welcome to the Conference
Natasha Kekre,BSc, MD, MPH, FRCPC, David Allan, MD, FRCPC

 From the Beginnings to Now and Beyond: The CBMTG Story  and Introduction of the CBMTG Special Recognition Award
Lothar Huebsch, MD, FRCPC

 CBMTG Special Recognition Award Lecture
Hans Messner, MD, PhD

 Immunoablation and Autologous Transplant for Immune  Disorders
Harold Atkins, MD, FRCPC

 CD34 Selection in Allogeneic Transplantation to Prevent Graft  Versus Host Disease
Sergio Giralt, MD

12:15pm – 1:45pm

  Corporate Symposium with Lunch

 2:00pm – 5:00pm

 Session 2A: Science
Chair: Natasha Kekre, BSc, MD, MPH, FRCPC

 Till and McCulloch Lectureship: Stem Cell Engineering to Improve Blood Stem Cell  Transplantation
Peter Zandstra, BEng, PhD, FAAAS, FAIMBE, FRSC, PEng

 Understanding the Marrow Microenvironment in Leukemia and  Hematopoietic Transplantation
Mick Bhatia, PhD

 Clinical Trials of Inducing Immune Tolerance in Allogeneic Bone  Marrow Transplant
Denis Claude-Roy, PhD, FRCPC, MD

 2:00pm – 5:00pm

 Session 2B: Nursing
Chairs: Linda Hamelin, RN, MN,  Jennifer Wiernikowski, RN (EC),   MN, NP-Adult, CON(C)

 Management of Out-Patients Undergoing Chimeric Antigen  Receptor T Cell Therapy
Ronan Foley, MD, FRCPC, Jennifer Wiernikowski, MN, NP-Adult, CON(C)   

 Refractory Leukemia: To Transplant or Not
Mitchell Sabloff,  M.Sc, MDCM

 Chronic Graft Versus Host Disease and Wound Care

2:00pm – 5:00pm

 Session 2C: Laboratory
Chair: Mike Halpenny, MLT (CMLTD)

 Cord Blood Updates:

 • Canadian Blood Services Heidi Elmoazzen, PhD

 • Héma-Québec Diane Fournier, PhD

 • Clinical Updates -Donna Wall, MD, CCPE

 GMP on a Shoestring, a Cost Effective Manufacturing Model
Qingdong Guan, PhD

CAR-T Cells in Canada: a New Model to Achieve Sustainability  While Fostering Innovation
Brad Nelson, PhD

 Regenerative Medicine is in Motion: Are You Ready?
 Linda Peltier, PhD

2:00pm – 5:00pm

 Session 2D: Pharmacy
Chair: Melanie Trinacty, BSc, B. Pharm

 Steroid Refractory GVHD and Oral GVHD

 Bone Marrow Transplant Pharmacist Practice Issues and Future Research Ideas
Jennifer Jupp, BPharm

 Preparative Regimens in the Elderly
Mark Brown, PharmD

5:00pm – 6:00pm

 Welcome Reception

 6:30pm – 8:00pm

 Corporate Symposium with Dinner

 Day 2 - Friday, June 8, 2018

 7:00am – 8:45am

 Corporate Symposium with Breakfast

9:00am – 10:00am

 Session 3: Registries and Transplant
Chair: Kristjan Paulson, MD

Kristjan Paulson, MD

 Recent Trends in Transplant Care and Future Directions
Mary Horowitz, MD, MS

10:15am - 11:15am


11:30am – 1:00pm

 Corporate Symposium with Lunch

1:15pm - 3:15pm

 Session 4: Navigating BMT and Cellular Therapy within the Canadian Health Care System
Chair: Matthew Seftel, MD

 Perspectives on New Therapeutics from the Pan-Canadian Oncology Drug Review

 Choosing Wisely: Blood and Marrow Transplant
Sita Bhella, MD

 Exploiting Science? Complementary and Alternative Medicine   Clinics' Marketing of Unproven Stem Cell Therapies
Blake Murdoch, BA, JD, MBA

3:30pm – 5:00pm

 Oral Abstract Presentations
 Chair: Andrew Daly, MD

5:00pm – 6:00pm

Poster Abstract Presentations

 7:00pm Onwards

 Social Event

 Day 3 - Saturday, June 9, 2018

7:00am – 8:45am

 Corporate Symposium with Breakfast

 9:00am – 10:30am

 Session 5A: Special Topics in Adult Transplant
Chair: Isabelle Bence-Bruckler, MD

 Minimal Residual Disease in Transplantation for Adult Acute  Lymphoblastic Leukemia
David Sanford, MD, FRCPC

 Maintenance Therapy After Autologous Transplant for  Lymphoma
Doug Stewart, MD

 9:00am – 10:30am

 Session 5B: Special Topics in Pediatric Transplant
Chair: Michel Duval, MD

 Debate: What is the Best Approach for Haplo Identical   Transplant in Bone Marrow Transplant?

  •  Ex-vivo Depletion Mary Slatter, MBChB, FRCPCH
  •  Post-transplant Cyclophosphamide Heather Symons,   MD, MHS

 Fred Saunders Lectureship: Chronic Graft Versus Host Disease   History, Biology, and Biomarkers
Kirk Schultz, MD

11:00am – 12:30pm

 Session 6: Donor Choice
Chair: David Allan, MD

 Debate: Who is the Best Donor for Allogeneic Transplant?

  •  Haplo Donors? -Mohamad Mohty, MD, PhD
  •  Unrelated Adult Donors?Chris Bredeson, MD, MSc, FRCPC
  •  Cord Blood Donors?  Sandra Cohen , MD
12:45pm – 2:15pm

 Corporate Symposium with Lunch

2:30pm – 5:00pm

 CBMTG Committee and SIG Meetings

5:00pm – 8:00pm

 Patient and Caregiver Symposium
Chair: David Jones, MD, FRCPC


This website is sponsored by an unrestricted educational grant from:

Follow CBMTG